Melanoma
Research Highlights/News
2024 | 2023 | 2022 | 2021 | 2020 | 2019
» Look for consumer stories click here
2024
Press Releases:
- Department of Defense Melanoma Research Program Anticipated Funding Opportunities for Fiscal Year 2024 (FY24)
February 8, 2024
Video Highlights:
2023
Press Releases:
- Department of Defense Melanoma Research Program Anticipated Funding Opportunities for Fiscal Year 2023 (FY23)
March 7, 2023
Research Highlights:
2022
Press Releases:
- Department of Defense Melanoma Research Program Anticipated Funding Opportunities for Fiscal Year 2022 (FY22)
April 4, 2022
Research Highlights:
- Beyond Sunscreen: Redefining Melanoma Prevention
- Introducing the Melanoma Academy
- The Melanoma Research Program‘s Renewed Focus on Rare Melanomas and a New Funding Opportunity
- Oncoprotein “RLIP” as a Novel Therapeutic Target for Melanoma Prevention and Treatment
2021
Press Releases:
- Department of Defense Melanoma Research Program Anticipated Funding Opportunities for Fiscal Year 2021 (FY21)
March 31, 2021
Research Highlights:
- Fiscal Year 2021 Melanoma Research Program Academy: An Opportunity for Leadership
- Breaking the Habit: Melanoma Cells Dependence on BRAF+MEK Inhibitors
- Improving Therapy for Melanoma Brain Metastases
- Identification of the HDAC Inhibitor Quisinostat as a Possible Therapeutic for Uveal Melanoma
2020
Press Releases:
- Department of Defense Melanoma Research Program Anticipated Funding Opportunities for Fiscal Year 2020 (FY20)
March 23, 2020
Research Highlights:
- Exploring Novel Ideas in Melanoma Research
- FY20 Melanoma Research Program: Filling the Gaps in Research for a Better Future
- Siah2: A Potential Biomarker to Predict Immunotherapy Treatment Outcomes in Melanoma Patients
- Role of the Inhibitory Receptor TIGIT in the Regulation of CD4+ Tregs in Patients with Advanced Melanoma
2019
Press Releases:
- Department of Defense Melanoma Research Program Funding Opportunities for Fiscal Year 2019 (FY19)
April 8, 2019
Research Highlights
Last updated Wednesday, May 1, 2024